The accumulation of 2-hydroxyglutarate in IDH mutant gliomas inhibits DNA and histone demethylation enzymes, referred to as dioxygenases, and leads to the development of the hypermethylated glioma CpG island phenotype [88]. The gene discussed is IDH1; the disease is central nervous system cancer.